The venture secondary market is evolving fast. In this conversation, VenCap’s Matt Russell shares why investors should look beyond headline discounts and focus instead on asset quality, valuation discipline, and the underlying strength of portfolios. With deal quality rising and liquidity needs intensifying, his insights offer a clear view into the next phase of venture secondaries.
As private equity adapts to a prolonged high-cost environment, investors are being forced to rethink how they source deals, create value, and deploy capital. Ahead of her appearance at 0100 Europe (April 21–23), we spoke with Geraldine O’Keeffe, Partner at EQT Healthcare Growth, about how one of Europe’s leading investment platforms is transiting today’s market dynamics—across healthcare, technology, and beyond.
